Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion
Go back to Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion| Danaher Corp. (NYSE: DHR) | Delayed: 215.84 +4.03 (1.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $211.81 | 52 Week High | $102.79 | |||
| Open | $212.03 | 52 Week Low | $75.71 | |||
| Day High | $216.19 | P/E | 56.80 | |||
| Day Low | $209.60 | EPS | $3.80 | |||
| Volume | 5,164,052 | |||||
| General Electric (NYSE: GE) | Delayed: 319.01 +4.74 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $314.27 | 52 Week High | $33.00 | |||
| Open | $317.54 | 52 Week Low | $27.10 | |||
| Day High | $322.14 | P/E | 217.01 | |||
| Day Low | $313.81 | EPS | $1.47 | |||
| Volume | 3,799,213 | |||||
